Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Joseph Gómez has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Untangling the Microscopic World of Organelles, Cells, Tissues, and Organs: A Focus on the Dysfunctional Golgi Apparatus in Disease Research

    by Daniel Joseph Gómez

    Emerging techniques in organelle structural biology have revolutionized our understanding of disease mechanisms and opened new possibilities for developing targeted therapies. In particular, dysfunctions of the Golgi apparatus (GA) have been implicated in a wide range of neurological disorders and cancer, making it a key area of focus in organelle structural biology. The GA plays a crucial role in regulating the transport and modification of proteins and lipids, and dysfunction of this organelle can lead to mislocation and accumulation of proteins and impaired glycosylation, resulting in neurodegenerative diseases such as Parkinson’s Disease and neurodevelopmental disorders (NDDs). Inhibition of vesicular trafficking by α-synuclein may affect dopamine-producing neurons and neuromodulators, while fragmentation and defects within the GA can lead to apoptotic pathways during pathological mechanisms. Additionally, defects and fragmentation of the GA have been implicated in cancer progression, making it a key area of interest for cancer researchers. Advances in imaging technology, such as cryogenic electron tomography, soft-X-ray tomography (SXT), and multiplex correlative light and electron microscopy (CLEM), have enabled high-resolution visualization of the GA and its dysfunctions in neurological diseases and cancer. These techniques provide detailed insight into the structure and function of the GA and have the potential to inform new treatments for diseases associated with GA dysfunction. Recent studies have shown that molecular zippers hold the Golgi membrane together, providing further insight into the mechanisms underlying GA dysfunction in diseases such as Parkinson’s, NDDs, and cancer. Cryo-CLEM and nanobody-assisted tissue immunostaining for volumetric EM (NATIVE) techniques enable high-resolution visualization of the GA and its native environment, aiding in understanding its function in health and disease. In addition, novel techniques such as Optical coherence tomography (OCT) enable rapid, accurate, and high-resolution in vivo imaging of the mouse cortex, providing 3D visualization of cortical microarchitecture using a feature segmentation algorithm. OCT enables label-free, micron-scale 3D imaging of biological tissues’ fine structures with significant depth and a large field of view. A 3D CNS segmentation mask of brain neural networks in a living mouse can be visualized at micron-level resolution using OCT. Overall, the organelle structural biology field, specifically the study of the Golgi apparatus dysfunction in neurological disorders and cancer, has significant implications for developing new therapeutic targets, gene therapy, and drug design. With continued research and advancements in imaging technologies, we can expect to gain a more comprehensive understanding of the underlying mechanisms of GA dysfunction in neurological disorders and cancer, paving the way for innovative new treatments and therapies.

  • Open Access

    Pioneering Organelle Structural Biology: Golgi Apparatus Dysfunction in Parkinson’s Disease, Neurodevelopmental Disorders, and Cancer

    by Daniel Gómez

    The Golgi apparatus (GA) dysfunctions in Parkinson’s Disease (PD), neurodevelopmental disorders (NDDs), cancer, and organelle structural biology (OSB) can provide insights into therapeutic targets, gene therapy, and drug design. Primary defects and fragmentation within the GA are implicated in a wide range of neurodegenerative diseases. GA defects typically result in mislocation of proteins, accumulation of undegraded proteins, and impaired glycosylation of proteins. Inhibition of vesicular trafficking by α-synuclein (aSyn) may affect the dopamine-producing neurons and neuromodulators. GA regulates apoptosis during pathological mechanisms of neurological diseases and could provide new avenues in treatments through translation research. PD patients bearing the hereditary E46K disease mutation manifest the clinical picture of parkinsonism. How do we provide high resolution nanoimages of the GA during disease to capture dysfunction? Could we visualize the aSyn traffic jam between vesicles in the organelles ER and GA? OSB is emerging as a field as more technology advances and is more accessible. Structural studies of the GA will advance the field of neurological disease forward with an in depth understanding of dysfunction, fragmentation, and defects. Discoveries of the GA in PD, NDDs, and cancer would break new ground and provide translational medicine data of these diseases. Future research could be visualizing high angle annular dark field-STEM (HAADF-STEM) tomograms, cryogenic electron tomography (cryo-ET), multiplex correlative light and electron microscopy (cryo-CLEM), nanobody-assisted tissue immunostaining for volumetric EM (NATIVE) and using soft X-ray tomography (SXT) and computational reconstruction of the GA.

  • Open Access

    Pioneering Organelle Structural Biology: Golgi Apparatus Dysfunction in Parkinson’s Disease, Neurodevelopmental Disorders, and Cancer

    by Daniel Joseph Gomez

    The Golgi apparatus (GA) dysfunctions in Parkinson’s Disease (PD), neurodevelopmental disorders (NDDs), cancer, and organelle structural biology (OSB) can provide insights into therapeutic targets, gene therapy, and drug design. Primary defects and fragmentation within the GA are implicated in a wide range of neurodegenerative diseases. GA defects typically result in mislocation of proteins, accumulation of undegraded proteins, and impaired glycosylation of proteins. Inhibition of vesicular trafficking by α-synuclein (aSyn) may affect the dopamine-producing neurons and neuromodulators. GA regulates apoptosis during pathological mechanisms of neurological diseases and could provide new avenues in treatments through translation research. PD patients bearing the hereditary E46K disease mutation manifest the clinical picture of parkinsonism. How do we provide high resolution nanoimages of the GA during disease to capture dysfunction? Could we visualize the aSyn traffic jam between vesicles in the organelles ER and GA? OSB is emerging as a field as more technology advances and is more accessible. Structural studies of the GA will advance the field of neurological disease forward with an in depth understanding of dysfunction, fragmentation, and defects. Discoveries of the GA in PD, NDDs, and cancer would break new ground and provide translational medicine data of these diseases. Future research could be visualizing high angle annular dark field-STEM (HAADF-STEM) tomograms, cryogenic electron tomography (cryo-ET), multiplex correlative light and electron microscopy (cryo-CLEM), nanobody-assisted tissue immunostaining for volumetric EM (NATIVE) and using soft X-ray tomography (SXT) and computational reconstruction of the GA.

  • Open Access

    Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses

    by Tania H. Mulherkar, Daniel Joseph Gómez, Grace Sandel, Pooja Jain

    Dendritic cells (DCs) function as a link between innate and adaptive immune responses. Retroviruses HIV-1 and HTLV-1 modulate DCs to their advantage and utilize them to propagate infection. Coinfection of HTLV-1 and HIV-1 has implications for cancer malignancies. Both viruses initially infect DCs and propagate the infection to CD4+ T cells through cell-to-cell transmission using mechanisms including the formation of virologic synapses, viral biofilms, and conduits. These retroviruses are both neurotrophic with neurovirulence determinants. The neuropathogenesis of HIV-1 and HTLV-1 results in neurodegenerative diseases such as HIV-associated neurocognitive disorders (HAND) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Infected DCs are known to traffic to the brain (CNS) and periphery (PNS, lymphatics) to induce neurodegeneration in HAND and HAM/TSP patients. Elevated levels of neuroinflammation have been correlated with cognitive decline and impairment of motor control performance. Current vaccinations and therapeutics for HIV-1 and HTLV-1 are assessed and can be applied to patients with HIV-1-associated cancers and adult T cell leukemia/lymphoma (ATL). These diseases caused by co-infections can result in both neurodegeneration and cancer. There are associations with cancer malignancies and HIV-1 and HTLV-1 as well as other human oncogenic viruses (EBV, HBV, HCV, HDV, and HPV). This review contains current knowledge on DC sensing of HIV-1 and HTLV-1 including DC-SIGN, Tat, Tax, and current viral therapies. An overview of DC interaction with oncogenic viruses including EBV, Hepatitis viruses, and HPV is also provided. Vaccines and therapeutics targeting host–pathogen interactions can provide a solution to co-infections, neurodegeneration, and cancer.